240550 — DongBang Medical Co Balance Sheet
0.000.00%
- KR₩143bn
- KR₩145bn
- KR₩114bn
Annual balance sheet for DongBang Medical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Cash | ||||
| Cash and Equivalents | ||||
| Short Term Investments | ||||
| Cash and Short Term Investments | 18,963 | 16,491 | 16,945 | 33,528 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | 14,032 | 15,679 | 20,313 | 22,330 |
| Total Inventory | ||||
| Prepaid Expenses | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 60,073 | 63,393 | 72,574 | 96,305 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | 40,802 | 40,993 | 57,422 | 67,281 |
| Net Goodwill | ||||
| Net Intangible Assets | ||||
| Long Term Investments | ||||
| Long Term Notes Receivable | ||||
| Other Long Term Assets | ||||
| Total Assets | 113,736 | 117,001 | 150,351 | 186,529 |
| Accounts Payable | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 59,051 | 53,630 | 50,383 | 45,483 |
| Long Term Debt | ||||
| Capital Lease Obligations | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Minority Interest | ||||
| Total Other Liabilities | ||||
| Total Funded Status | ||||
| Total Liabilities | 77,333 | 70,211 | 70,442 | 63,641 |
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| ESOP Debt Guarantee | ||||
| Unrealized Gain / Loss | ||||
| Other Equity | ||||
| Total Equity | 36,403 | 46,790 | 79,909 | 122,888 |
| Total Liabilities & Shareholders' Equity | 113,736 | 117,001 | 150,351 | 186,529 |
| Total Common Shares Outstanding |